Freestone Grove Partners LP

Position in BIIB — Biogen Inc.

CIK 2007591 San Francisco, CA

Position in BIIB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,117,279

-$14,899,852 QoQ

Shares Held

83,853

-55.3% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#129

of 1,036 holders

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Freestone Grove Partners LP holds $182,044,995 across 6 Drug Manufacturers - General names. BIIB ranks #2 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	517,230	$131,360,903
2	BIIB	Biogen Inc. This page	83,853	$18,117,279
3	LLY	ELI LILLY & Co	13,442	$16,122,739
4	PFE	Pfizer Inc	335,530	$8,079,562
5	BMY	Bristol Myers Squibb Co	84,601	$4,874,709
6	MRK	Merck & Co., Inc.	27,158	$3,489,803

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,117,279	83,853	-55.3%	Shares	Sole	2026-08-14
2025-12-31	$33,017,131	187,608	-14.3%	Shares	Sole	2026-02-17
2025-09-30	$30,658,749	218,866	+97.2%	Shares	Sole	2025-11-14
2025-06-30	$13,940,992	111,004	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.